Skip to main content
Caplight Logo









S3V Vascular Technologies

S3V Vascular Technologies

Private
MysuruHealthcare & Life Scienceshttp://s3vvascular.com/

Last Round

Series B

Mar 14, 2024

Total Funding Raised

$43.52M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

S3V Vascular Technologies is a medical devices company that develops, manufactures, and markets minimally invasive cardiovascular, neurovascular, and critical-care medical devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical device manufacturingminimally invasive devicesmedtechinterventional devicescardiovascular devicesdrug-eluting stentsneurovascular devicesmechanical thrombectomymade in India medical devicesaffordable medical devicesballoon catheterstroke treatmenttranscatheter aortic valve replacementTAVRmedical device contract manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

S3V Vascular Technologies Comparables

Compare S3V Vascular Technologies with similar companies based on industry and business-model similarity.

S3V Vascular Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Relisys Medical Devices
86%
Translumina Therapeutics
84%
Sahajanand Medical Technologies Limited
83%

S3V Vascular Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 14, 2024
Series AJul 1, 2022
DebtMay 9, 2017
SeedAug 9, 2011

S3V Vascular Technologies Investors

Notable investors and investment history

S3V Vascular Technologies investors
InvestorRounds
Jain International Trade OrganisationSeries A
Technology Development BoardDebt, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 16, 13% of headcount.

  • Jul 13, 2026

    Open roles increased to 16, 5.3x the trailing average.

S3V Vascular Technologies Filings

Explore SEC and related filing metadata, where available.

S3V Vascular Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about S3V Vascular Technologies's valuation, stock price, and market status.

Is S3V Vascular Technologies a public or private company?

S3V Vascular Technologies is a private company.

What is the current stock price of S3V Vascular Technologies?

S3V Vascular Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is S3V Vascular Technologies worth (valuation)?

Valuation information for S3V Vascular Technologies is not publicly available.

Can I buy S3V Vascular Technologies stock?

S3V Vascular Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was S3V Vascular Technologies's last funding round?

S3V Vascular Technologies's most recent funding round was Series B on March 14, 2024.

Who are the main investors in S3V Vascular Technologies?

Key investors in S3V Vascular Technologies include Jain International Trade Organisation, Technology Development Board.

Will S3V Vascular Technologies IPO soon?

No public IPO plans have been announced for S3V Vascular Technologies.

How can I track S3V Vascular Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor S3V Vascular Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMysuru
Employee Range123
Year Founded2011
Last FundingMar 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?